{"title":"Microarray analysis of signalling interactions between inflammation and angiogenesis in subchondral bone in temporomandibular joint osteoarthritis.","authors":"Wenpin Qin, Jialu Gao, Jianfei Yan, Xiaoxiao Han, Weicheng Lu, Zhangyu Ma, Lina Niu, Kai Jiao","doi":"10.12336/biomatertransl.2024.02.007","DOIUrl":"10.12336/biomatertransl.2024.02.007","url":null,"abstract":"<p><p>Inflammation and angiogenesis, the major pathological changes of osteoarthritis (OA), are closely associated with joint pain; however, pertinent signalling interactions within subchondral bone of osteoarthritic joints and potential contribution to the peripheral origin of OA pain remain to be elucidated. Herein we developed a unilateral anterior crossbite mouse model with osteoarthritic changes in the temporomandibular joint. Microarray-based transcriptome analysis, besides quantitative real-time polymerase chain reaction, was performed to identify differentially expressed genes (DEGs). Overall, 182 DEGs (fold change ≥ 2, P < 0.05) were identified between the control and unilateral anterior crossbite groups: 168 were upregulated and 14 were downregulated. On subjecting significant DEGs to enrichment analyses, inflammation and angiogenesis were identified as the most affected. Inflammation-related DEGs were mainly enriched in T cell activation and differentiation and in the mammalian target of rapamycin/nuclear factor-κB/tumour necrosis factor signalling. Furthermore, angiogenesis-related DEGs were mainly enriched in the Gene Ontology terms angiogenesis regulation and vasculature development and in the KEGG pathways of phosphoinositide 3-kinase-protein kinase B/vascular endothelial growth factor/hypoxia-inducible factor 1 signalling. Protein-protein interaction analysis revealed a close interaction between inflammation- and angiogenesis-related DEGs, suggesting that phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta (Pi3kcd), cathelicidin antimicrobial peptide (Camp), C-X-C motif chemokine receptor 4 (Cxcr4), and MYB proto-oncogene transcription factor (Myb) play a central role in their interaction. To summarize, our findings reveal that in subchondral bone of osteoarthritic joints, signal interaction is interrelated between inflammation and angiogenesis and associated with the peripheral origin of OA pain; moreover, our data highlight potential targets for the inhibition of OA pain.</p>","PeriodicalId":58820,"journal":{"name":"Biomaterials Translational","volume":"5 2","pages":"175-184"},"PeriodicalIF":0.0,"publicationDate":"2024-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11438608/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Biomaterials TranslationalPub Date : 2024-03-28eCollection Date: 2024-01-01DOI: 10.12336/biomatertransl.2024.01.003
Zhangjie Li, Dingyuan Yu, Chenyang Zhou, Feifan Wang, Kangyi Lu, Yijun Liu, Jiaqi Xu, Lian Xuan, Xiaolin Wang
{"title":"Engineering vascularised organoid-on-a-chip: strategies, advances and future perspectives.","authors":"Zhangjie Li, Dingyuan Yu, Chenyang Zhou, Feifan Wang, Kangyi Lu, Yijun Liu, Jiaqi Xu, Lian Xuan, Xiaolin Wang","doi":"10.12336/biomatertransl.2024.01.003","DOIUrl":"10.12336/biomatertransl.2024.01.003","url":null,"abstract":"<p><p>In recent years, advances in microfabrication technology and tissue engineering have propelled the development of a novel drug screening and disease modelling platform known as organoid-on-a-chip. This platform integrates organoids and organ-on-a-chip technologies, emerging as a promising approach for in vitro modelling of human organ physiology. Organoid-on-a-chip devices leverage microfluidic systems to simulate the physiological microenvironment of specific organs, offering a more dynamic and flexible setting that can mimic a more comprehensive human biological context. However, the lack of functional vasculature has remained a significant challenge in this technology. Vascularisation is crucial for the long-term culture and in vitro modelling of organoids, holding important implications for drug development and personalised medical approaches. This review provides an overview of research progress in developing vascularised organoid-on-a-chip models, addressing methods for in vitro vascularisation and advancements in vascularised organoids. The aim is to serve as a reference for future endeavors in constructing fully functional vascularised organoid-on-a-chip platforms.</p>","PeriodicalId":58820,"journal":{"name":"Biomaterials Translational","volume":"5 1","pages":"21-32"},"PeriodicalIF":0.0,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362354/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142115519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Biomaterials TranslationalPub Date : 2024-03-28eCollection Date: 2024-01-01DOI: 10.12336/biomatertransl.2024.01.005
Xiaoxiang Ren, Ruixue Xu, Chenjie Xu, Jiacan Su
{"title":"Harnessing exosomes for targeted therapy: strategy and application.","authors":"Xiaoxiang Ren, Ruixue Xu, Chenjie Xu, Jiacan Su","doi":"10.12336/biomatertransl.2024.01.005","DOIUrl":"10.12336/biomatertransl.2024.01.005","url":null,"abstract":"<p><p>Exosomes, nanoscopic extracellular vesicles produced by cells, are pivotal in mediating intracellular communication by transporting nucleic acids, proteins, lipids, and other bioactive molecules, thereby influencing physiological and pathological states. Their endogenous origin and inherent diversity confer distinct advantages over synthetic vehicles like liposomes and nanoparticles in diagnostic and therapeutic applications. Despite their potential, the clinical utility of exosomes is hampered by challenges such as limited storage stability, yield, purity, and targeting efficiency. This review focuses on exosomes as targeted therapeutic agents, examining their biogenesis, classification, isolation, and characterisation, while also addressing the current limitations in yield, purity, and targeting. We delve into the literature to propose optimisation strategies that can enhance their therapeutic efficacy and accelerate the translation of exosome-based therapies into clinical practice.</p>","PeriodicalId":58820,"journal":{"name":"Biomaterials Translational","volume":"5 1","pages":"46-58"},"PeriodicalIF":0.0,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362351/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142115521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Biomaterials TranslationalPub Date : 2024-03-28eCollection Date: 2024-01-01DOI: 10.12336/biomatertransl.2024.01.002
Lei Qi, Tong Zhao, Jinge Yan, Weiwen Ge, Weidong Jiang, Jing Wang, Mazaher Gholipourmalekabadi, Kaili Lin, Xiuhui Wang, Lei Zhang
{"title":"Advances in magnesium-containing bioceramics for bone repair.","authors":"Lei Qi, Tong Zhao, Jinge Yan, Weiwen Ge, Weidong Jiang, Jing Wang, Mazaher Gholipourmalekabadi, Kaili Lin, Xiuhui Wang, Lei Zhang","doi":"10.12336/biomatertransl.2024.01.002","DOIUrl":"10.12336/biomatertransl.2024.01.002","url":null,"abstract":"<p><p>Reconstruction of bone defects or fractures caused by ageing, trauma and tumour resection is still a great challenge in clinical treatment. Although autologous bone graft is considered as gold standard, the source of natural bone is limited. In recent years, regenerative therapy based on bioactive materials has been proposed for bone reconstruction. Specially, numerous studies have indicated that bioactive ceramics including silicate and phosphate bioceramics exhibit excellent osteoinductivity and osteoconductivity, further promote bone regeneration. In addition, magnesium (Mg) element, as an indispensable mineral element, plays a vital role in promoting bone mineralisation and formation. In this review, different types of Mg-containing bioceramics including Mg-containing calcium phosphate-based bioceramics (such as Mg-hydroxyapatite, Mg-biphasic calcium phosphate), Mg-containing calcium silicate-based bioceramics (such as Mg<sub>2</sub>SiO<sub>4</sub>, Ca<sub>2</sub>MgSi<sub>2</sub>O<sub>7</sub> and Mg-doped bioglass), Mg-based biocements, Mg-containing metal/polymer-bioceramic composites were systematacially summarised. Additionally, the fabrication technologies and their materiobiological effects were deeply discussed. Clinical applications and perspectives of magnesium-containing bioceramics for bone repair are highlighted. Overall, Mg-containing bioceramics are regarded as regenerative therapy with their optimised performance. Furthermore, more in-depth two-way researches on their performance and structure are essential to satisfy their clinical needs.</p>","PeriodicalId":58820,"journal":{"name":"Biomaterials Translational","volume":"5 1","pages":"3-20"},"PeriodicalIF":0.0,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362349/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142115518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Biomaterials TranslationalPub Date : 2024-03-28eCollection Date: 2024-01-01DOI: 10.12336/biomatertransl.2024.01.006
Huaxin Yang, Mengjia Zheng, Yuyue Zhang, Chaochang Li, Joseph Ho Chi Lai, Qizheng Zhang, Kannie Wy Chan, Hao Wang, Xin Zhao, Zijiang Yang, Chenjie Xu
{"title":"Enhanced angiogenesis in porous poly(ε-caprolactone) scaffolds fortified with methacrylated hyaluronic acid hydrogel after subcutaneous transplantation.","authors":"Huaxin Yang, Mengjia Zheng, Yuyue Zhang, Chaochang Li, Joseph Ho Chi Lai, Qizheng Zhang, Kannie Wy Chan, Hao Wang, Xin Zhao, Zijiang Yang, Chenjie Xu","doi":"10.12336/biomatertransl.2024.01.006","DOIUrl":"10.12336/biomatertransl.2024.01.006","url":null,"abstract":"<p><p>A composite scaffold composed of a porous scaffold and hydrogel filling can facilitate engraftment, survival, and retention in cell transplantation processes. This study presents a composite scaffold made of poly(ε-caprolactone) (PCL) and methacrylated hyaluronic acid (MeHA) hydrogel and describes the corresponding physical properties (surface area, porosity, and mechanical strength) and host response (angiogenesis and fibrosis) after subcutaneous transplantation. Specifically, we synthesise MeHA with different degrees of substitution and fabricate a PCL scaffold with different porosities. Subsequently, we construct a series of PCL/MeHA composite scaffolds by combining these hydrogels and scaffolds. In experiments with mice, the scaffold composed of 3% PCL and 10-100 kDa, degree of substitution 70% MeHA results in the least fibrosis and a higher degree of angiogenesis. This study highlights the potential of PCL/MeHA composite scaffolds for subcutaneous cell transplantation, given their desirable physical properties and host response.</p>","PeriodicalId":58820,"journal":{"name":"Biomaterials Translational","volume":"5 1","pages":"59-68"},"PeriodicalIF":0.0,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362355/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142117126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Biomaterials TranslationalPub Date : 2024-03-28eCollection Date: 2024-01-01DOI: 10.12336/biomatertransl.2024.01.010
Kaibo Zhang, Weili Fu
{"title":"HIF-1<i>α</i>: linking subchondral bone and cartilage as a therapeutic target in osteoarthritis.","authors":"Kaibo Zhang, Weili Fu","doi":"10.12336/biomatertransl.2024.01.010","DOIUrl":"10.12336/biomatertransl.2024.01.010","url":null,"abstract":"","PeriodicalId":58820,"journal":{"name":"Biomaterials Translational","volume":"5 1","pages":"89-91"},"PeriodicalIF":0.0,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362353/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142115522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Biomaterials TranslationalPub Date : 2024-03-28eCollection Date: 2024-01-01DOI: 10.12336/biomatertransl.2024.01.008
Yan Xu, Fuxin Wei
{"title":"Large scale, high purity, high quality isolation of mesenchymal stem cells from osteo-organoids.","authors":"Yan Xu, Fuxin Wei","doi":"10.12336/biomatertransl.2024.01.008","DOIUrl":"10.12336/biomatertransl.2024.01.008","url":null,"abstract":"","PeriodicalId":58820,"journal":{"name":"Biomaterials Translational","volume":"5 1","pages":"84-85"},"PeriodicalIF":0.0,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362352/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142115523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Biomaterials TranslationalPub Date : 2024-03-28eCollection Date: 2024-01-01DOI: 10.12336/biomatertransl.2024.01.004
Haoyu Guo, Mingke Guo, Zhidao Xia, Zengwu Shao
{"title":"Membrane-coated nanoparticles as a biomimetic targeted delivery system for tumour therapy.","authors":"Haoyu Guo, Mingke Guo, Zhidao Xia, Zengwu Shao","doi":"10.12336/biomatertransl.2024.01.004","DOIUrl":"10.12336/biomatertransl.2024.01.004","url":null,"abstract":"<p><p>Drug therapy towards tumours often causes adverse effects because of their non-specific nature. Membrane-coated technology and membrane-coated nanoparticles provide an advanced and promising platform of targeted and safe delivery. By camouflaging the nanoparticles with natural derived or artificially modified cell membranes, the nano-payloads are bestowed with properties from cell membranes such as longer circulation, tumour or inflammation-targeting, immune stimulation, augmenting the performance of traditional therapeutics. In this review, we review the development of membrane coating technology, and summarise the technical details, physicochemical properties, and research status of membrane-coated nanoparticles from different sources in tumour treatment. Finally, we also look forward to the prospects and challenges of transforming membrane coating technology from experiment into clinical use. Taken together, membrane-coated nanoparticles are bound to become one of the most potential anti-tumour strategies in the future.</p>","PeriodicalId":58820,"journal":{"name":"Biomaterials Translational","volume":"5 1","pages":"33-45"},"PeriodicalIF":0.0,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362346/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142115524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Biomaterials TranslationalPub Date : 2024-03-28eCollection Date: 2024-01-01DOI: 10.12336/biomatertransl.2024.01.009
Danli Cui, Yiting Lei
{"title":"Exploring the potential of micro-nano composite structures for COVID-19 vaccines and beyond.","authors":"Danli Cui, Yiting Lei","doi":"10.12336/biomatertransl.2024.01.009","DOIUrl":"10.12336/biomatertransl.2024.01.009","url":null,"abstract":"","PeriodicalId":58820,"journal":{"name":"Biomaterials Translational","volume":"5 1","pages":"86-88"},"PeriodicalIF":0.0,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11362350/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142117127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}